In this study, based on a considerable previous effort about the relationship between Mex3a levels and liver cancer development, we propose that a more effective strategy for detecting HCC is the combined test of AFP, Mex3a mRNA levels, and Mex3a promoter methylation levels. This evidence concerns the gene MEX3A and liver cancer.